Multi-centre, multi-database studies with common protocols: Lessons learnt from the IMI PROTECT project
Autor: | Klungel, Olaf H., Kurz, Xavier, de Groot, Mark C. H., Schlienger, Raymond G., Tcherny-Lessenot, Stephanie, Grimaldi, Lamiae, Ibáñez, Luisa, Groenwold, Rolf H. H., Reynolds, Robert F., Alvarez, Y., Candore, G., Durand, J., Slattery, J., Hasford, J., Rottenkolber, M., Schmiedl, S., de Abajo Iglesias, F., Gil, M., Gonzalez, R., Huerta Alvarez, C., Martin, E., Oliva, B., Requena, G., Amelio, J., Brauer, R., Downey, G., Feudjo-Tepie, M., Schoonen, M., Johansson, S., Robinson, J., Gallagher, A., Ng, E., van Staa, T.P., Davis, K., Abbing-Karahagopian, V., Ali, S., Belitser, S., de Boer, Anthonius, De Bruin, M.L., Egberts, A.C.G., van Dijk, L., Gardarsdottir, H., Leufkens, H.G.M., Souverein, P., Uddin, J., van den Ham, H.A., Voogd, E., de Vries, Frank, Udo, R., Sub Pharmacotherapy, Theoretical, Sub Gen. Pharmacoepi and Clinical Pharm, Sub Pharmacoepidemiology, Sub Clinical Pharmacy, Pharmacoepi, Pharmacoepidemiology and Clinical Pharmacology |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2016 |
Předmět: |
Pharmacoepidemiology (PE)
pharmacoepidemiology anticonvulsive agent study design data base European Medicines Agency Taverne antibiotic agent antidepressant agent human Innovative Medicines Initiative replication study Observational studies outcome assessment suicide benzodiazepine derivative long acting drug beta 2 adrenergic receptor stimulating agent Methodology tricyclic antidepressant agent article asthma case control study long acting beta 2 adrenergic receptor stimulating agent unclassified drug acute heart infarction confounding variable calcium channel blocking agent priority journal risk factor PROTECT hip fracture depression serotonin uptake inhibitor epilepsy observational study Electronic healthcare databases clinical protocol chronic obstructive lung disease neoplasm liver injury |
Zdroj: | Pharmacoepidemiology and Drug Safety, 25(supplement S1), 156. John Wiley and Sons Ltd |
ISSN: | 1053-8569 |
Popis: | Purpose: To assess the impact of a variety of methodological parameters on the association between six drug classes and five key adverse events in multiple databases. Methods: The selection of Drug-Adverse Event pairs was based on public health impact, regulatory relevance, and the possibility to study a broad range of methodological issues. Common protocols and data analytical specifications were jointly developed and independently and blindly executed in different databases in Europe with replications in the same and different databases. Results: The association between antibiotics and acute liver injury, benzodiazepines and hip fracture, antidepressants and hip fracture, inhaled long-acting beta2-agonists and acute myocardial infarction was consistent in direction across multiple designs, databases and methods to control for confounding. Some variation in magnitude of the associations was observed depending on design, exposure and outcome definitions, but none of the differences were statistically significant. The association between anti-epileptics and suicidality was inconsistent across the UK CPRD, Danish National registries and the French PGRx system. Calcium channel blockers were not associated with the risk of cancer in the UK CPRD, and this was consistent across different classes of calcium channel blockers, cumulative durations of use up to >10years and different types of cancer. Conclusions: A network for observational drug effect studies allowing the execution of common protocols in multiple databases was created. Increased consistency of findings across multiple designs and databases in different countries will increase confidence in findings from observational drug research and benefit/risk assessment of medicines. |
Databáze: | OpenAIRE |
Externí odkaz: |